Shopping Cart
Remove All
Your shopping cart is currently empty
Cliramitug is a monoclonal antibody that targets human transthyretin protein (TTR). By binding to TTR, Cliramitug inhibits its amyloid formation process and exhibits activity that prevents amyloid deposition. Cliramitug holds potential for research in transthyretin amyloidosis-related diseases, including certain neurological and cardiovascular conditions.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Cliramitug is a monoclonal antibody that targets human transthyretin protein (TTR). By binding to TTR, Cliramitug inhibits its amyloid formation process and exhibits activity that prevents amyloid deposition. Cliramitug holds potential for research in transthyretin amyloidosis-related diseases, including certain neurological and cardiovascular conditions. |
| Synonyms | NI006 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | TTR |
| Cas No. | 2965214-50-8 |
| Isotype | IgG2SA |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.